Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 44.65
+0.40 (0.90%)
At close: Mar 27, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 3.36 billion as of March 27, 2026.
Market Cap
3.36B
Enterprise Value
2.56B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
44.65
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 3.36B, a decrease of -5.30%. That is a compound annual growth rate of -19.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.36B | -9.25% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Richmond International Travel & Tours Co.,Ltd | 3.45B |
| ATW Technology | 3.43B |
| Kingwaytek Technology | 3.42B |
| Celxpert Energy | 3.40B |
| Bon Fame | 3.38B |
| Merdury Biopharmaceutical | 3.35B |
| Shine-On BioMedical | 3.35B |
| ICARES Medicus | 3.34B |